Rep. Buddy Carter (R-GA) told CMS Administrator Seema Verma he is concerned about duplicate discounts between 340B and Medicaid, and he believes the 340B program needs to be improved. A Manatt Health survey shows that states are using a wide variety of strategies to help get a handle on this long-running issue. The drug discount program statute says that a drug cannot be subject to both 340B discounts and Medicaid rebates. The duplicate discounts have been an issue for some...